| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 04/06/2005 | CN1603338A Selenium-containing polypeptide and its use in medicine, food etc |
| 04/06/2005 | CN1603263A Use of glass compositions for achieving an antioxidative effect |
| 04/06/2005 | CN1195549C Stable amorphous amifostine compositions and methods for the preparation and use of same |
| 04/06/2005 | CN1195508C Use of inhibitors of sodium-hydrogen pump for production of medicament for decreaing undesired effects of substances on heart |
| 04/05/2005 | US6875789 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/05/2005 | CA2339621C 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 04/05/2005 | CA2276146C Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 03/31/2005 | WO2005027944A1 Oral compositions and route of administration for the delivery of a thylakoid extract |
| 03/31/2005 | WO2005027941A1 Skin preparation for external use |
| 03/31/2005 | WO2005027905A1 Pharmaceutical compositions for the treatment of organophosphate poisoning |
| 03/31/2005 | US20050070719 Central nervous system disorders; antidiabetic agents; antiinflammatory agents; antiarthritic agents;obesity; osteoporosis ; anticancer agents |
| 03/31/2005 | US20050070569 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 03/31/2005 | US20050069980 Transport protein for use as tool in altering in vivo pharmacokinetics of a pharmaceutical, toxic substance or xenobiotics by modulating an ability to transport acidic amino acids; antitumor agents |
| 03/31/2005 | CA2535208A1 Oral compositions and route of administration for the delivery of a thylakoid extract |
| 03/30/2005 | EP1517924A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 03/30/2005 | EP1517902A2 Lactone compounds, for use as antioxidant agents in pharmaceutical, cosmetic or food compositions |
| 03/30/2005 | EP1181035B1 Substantially oil-free cyclosporin compositions |
| 03/30/2005 | EP0929232B1 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
| 03/30/2005 | EP0791056B1 Lipid-cleavage enzyme complex |
| 03/30/2005 | CN1602307A Substituted 6h-dibenzo[c, h]chromenes as estrogenic agents |
| 03/30/2005 | CN1600322A Combination of propolis, preparation method and usage |
| 03/30/2005 | CN1194759C Tetrodotoxin conjugate and medicine composition having same |
| 03/30/2005 | CN1194717C Snake poison capsule for treating lung cancer and its preparation method |
| 03/29/2005 | CA2195745C Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 03/24/2005 | WO2005025574A2 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 03/24/2005 | WO2005025569A1 Use of known active ingredients as radical scavengers |
| 03/24/2005 | WO2005009419A3 Use of 5-methoxytryptamine as a cardioprotective agents |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050065205 Administering protein kinase C activator such as macrocyclic lactone; mixture with enzyme inhibitor and carrier |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents |
| 03/24/2005 | US20050064050 Administering an effective amount of thearubigin, a type of brown-colored pigment component of black tea extracted from the leaves by water, hot water or an alcohol; an oxidative derivative of theaflavin (1-oxo,2,8,9-tri(hydroxy),4,6-bis(3,5,7-trihydroxy)chroman-2-yl)-benzocycloheptene; drugs; foods |
| 03/24/2005 | US20050064014 Use of cystathionine |
| 03/24/2005 | US20050063905 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); polycythemia vera, macroglobulinemia (Waldenstrom syndrome), megakaryocytic myelosis, malignant histiocytosis |
| 03/24/2005 | DE102004041612A1 Extraction of carotene, Vitamin E and other minor components from natural oils and fats, for use in pharmaceuticals and food products, involves extraction of a concentrate with supercritical fluid, preferably carbon dioxide |
| 03/24/2005 | CA2538910A1 Use of known active ingredients as radical scavengers |
| 03/23/2005 | EP1516064A2 Methods of using 46828, a human acyl-coa synthetase |
| 03/23/2005 | EP1515966A1 Hydroxy pyranone derivative and preparation method thereof |
| 03/23/2005 | EP1515959A1 Pharmaceutical salts of reboxetine |
| 03/23/2005 | EP1515731A1 Anti-spasmodic comprising xenon |
| 03/23/2005 | EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 03/23/2005 | EP1515615A1 Nutritional composition for detoxification and cancer prevention |
| 03/23/2005 | EP1328268B1 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 03/23/2005 | EP1280528B1 R-eliprodil for treating glaucoma |
| 03/23/2005 | EP1098647B1 Compounds and compositions for treating tissue ischemia |
| 03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
| 03/23/2005 | CN1596983A Composition of nanometer SOD and ginseng or its extract and its preparation method |
| 03/23/2005 | CN1596982A Composition of nanometer SOD and astragalus root or its extract and its preparation method |
| 03/23/2005 | CN1596981A Composition of nanometer SOD and pueraria root or its extract and its preparation method |
| 03/23/2005 | CN1596975A Composition of nanometer SOD and animal medicine or its extract and its preparation method |
| 03/23/2005 | CN1596889A Vitamin E emulsion and its freeze-dried emulsion compound and preparation method |
| 03/23/2005 | CN1193761C Controllable release system of glucocorticoid and its preparation method |
| 03/23/2005 | CN1193753C Ginkgo leaf extract and injection fluid containing same |
| 03/23/2005 | CN1193744C Slow releasing micro-encapsulation compound antioxidant |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059616 administering flavonoids and optionally vitamin E or excipients for the prophylaxis of bone or cardiovascular disorders, headaches, hypertension, cancers, leukemia, arteriosclerosis, Alzheimer's disease, inflammatory diseases, rheumatic diseases, acne, alopecia or psoriasis |
| 03/16/2005 | EP1513880A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 03/16/2005 | EP1513834A1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same |
| 03/16/2005 | EP1513797A1 Agents and methods for the treatment of disorders associated with oxidative stress |
| 03/16/2005 | EP1513543A2 Fas peptide mimetics and uses thereof |
| 03/16/2005 | EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES |
| 03/16/2005 | EP1513495A1 Modified release pharmaceutical formulation |
| 03/16/2005 | EP1171143B9 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 03/16/2005 | EP0746321B1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 03/16/2005 | CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 03/16/2005 | CN1596111A Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 03/16/2005 | CN1596109A Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 03/16/2005 | CN1594319A Process for extracting ginkgolide, ginkgolide injection and process for preparing same |
| 03/16/2005 | CN1593646A Soybean peptide, its preparation and application |
| 03/16/2005 | CN1593543A Method for preparing compound Chinese medicinal tonifying liquor |
| 03/16/2005 | CN1593480A Fig buccal tablet and its preparing process |
| 03/15/2005 | US6866851 GFRα1-RET specific agonists and methods therefor |
| 03/10/2005 | WO2002087604A8 Preparations containing a combination of vitamin e and afamin |
| 03/10/2005 | US20050054675 Interferon $g(g) production promoter |
| 03/10/2005 | US20050054624 Administering steroid9such as estrogen) containing hydrophobic substitution such as adamamtane ring; Alzheimer's, Parkinson's, Huntington's disease; multiple sclerosis; amyotropic lateral sclerosis; stroke; antiischemic agents |
| 03/09/2005 | EP1512410A1 Use of a composition for treating organ tissue injury caused by reperfusion of blood flow following a period of ischemia |
| 03/09/2005 | EP1512400A1 Treatment of neurodegenerative diseases |
| 03/09/2005 | EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 03/09/2005 | EP1511774A1 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions |
| 03/09/2005 | EP1018008B1 Method of identification of leads or active compounds |
| 03/09/2005 | CN1589844A Cerebrum nurishment intensification prescription |
| 03/03/2005 | US20050050589 Soya cell strains with high isoflavone content |
| 03/03/2005 | US20050049205 Product from rose hips e.g. 3- beta -D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO); arthritis and osteoarthritis |
| 03/02/2005 | EP1510511A1 Gingerol analogues and use thereof |
| 03/02/2005 | EP1510137A1 Pyruvate enriched onion extract |
| 03/02/2005 | EP1201762B1 Process for producing lycopen |
| 03/02/2005 | EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/02/2005 | EP0871448B1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
| 03/02/2005 | CN1589269A Heteroindanes: a new class of potent cannabimimetic ligands |
| 03/02/2005 | CN1586560A Cordyceps, ginseng, pilose antller, fleece-flower root long life pill |
| 03/02/2005 | CN1586535A Liuweidihuang effervescent tablet and its preparing method |
| 03/02/2005 | CN1586502A Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use |
| 03/02/2005 | CN1586475A Vitamin C oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586463A Use of glutaraldehyde in preparing medicine for preventing animal toxic diseases |
| 03/01/2005 | US6861447 Method for producing a coenzyme Q10/γ-cyclodextrin complex |
| 03/01/2005 | US6861078 Plant extracts with anti-radical type action |
| 02/24/2005 | WO2004075907A9 Salutary compositions consisting of fungi containing lipids and thiocyanates |
| 02/24/2005 | US20050043394 For prophylaxis and therapy of diabetes mellitus, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases, neuropathic diseases, neuropathic pain and polyneuropathy; free fatty acids and/or fatty acid esters and uridine, deoxyuridine, uridine monophosphate, deoxyuridine monophosphate |
| 02/24/2005 | US20050043352 human YAK family of serine/threonine protein kinases (hyak); use treating diseases of the hematopoietic systems, including anemias, polycythemia, myelodysplastic syndrome, myelosuppression, cytopenia, male contraceptives; 2-(3-Chloro-phenylamino)-7-methoxy-quinoline-3-carboxylic acid for example |